Amal Ltd | Annual Report 2021-22 Note 27.11 Loans Disclosures pursuant to the Regulation 34(3) read with para A of Schedule V to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Section 186 (4) of the Companies Act, 2013. Particulars Purpose Amount outstanding as at Maximum balance during the year As at March 31, 2022 As at March 31, 2021 As at March 31, 2022 As at March 31, 2021 Subsidiary company: Amal Speciality Chemicals Ltd For pro j ect expenditure requirement 2,202.00 - 2,202.00 - Note 27.12 Disclosure requirement under MSMED Act, 2006 The Company has certain dues to suppliers (trade and capital) registered under Micro, Small and Medium Enterprises Development Act, 2006 (MSMEDAct). The disclosures pursuant to the saidMSMEDAct are as follows: (` lakhs) Particulars As at March 31, 2022 As at March 31, 20201 Principal amount due to suppliers registered under the MSMEDAct and remaining unpaid as at year end 1.69 26.71 Interest due to suppliers registered under theMSMEDAct and remaining unpaid as at year end - - Principal amounts paid to suppliers registered under the MSMED Act, beyond the appointed day during the year - - Interest paid, other than under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year - - Interest paid, under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond the appointed day during the year - - Interest due and payable towards suppliers registered under MSMED Act, for payments already made - - Further interest remaining due and payable for earlier years - - Above disclosures have been made based on information available with the Company, for suppliers who are registered as Micro, Small and Medium Enterprise under ‘The Micro, Small and Medium Enterprise Development Act, 2006’ as at March 31, 2022. The auditors have relied upon in respect of this matter.
RkJQdWJsaXNoZXIy MjA2MDI2